We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.18%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.36B
AUM Growth
+$200M
Cap. Flow
+$70.3M
Cap. Flow %
1.61%
Top 10 Hldgs %
17.48%
Holding
714
New
57
Increased
313
Reduced
227
Closed
46

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$27.6M
2
JNJ icon
Johnson & Johnson
JNJ
+$24.4M
3
ORCL icon
Oracle
ORCL
+$20.4M
4
MCHP icon
Microchip Technology
MCHP
+$17.1M
5
CPB icon
Campbell Soup
CPB
+$16.8M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$26.2M
2
JNPR
Juniper Networks
JNPR
+$18.7M
3
DGX icon
Quest Diagnostics
DGX
+$18.4M
4
PG icon
Procter & Gamble
PG
+$17.4M
5
SPLS
Staples Inc
SPLS
+$15M

Sector Composition

Rank Sector Weight
1 Healthcare 24.09%
2 Financials 14.65%
3 Technology 11.77%
4 Communication Services 9.13%
5 Consumer Staples 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
376
Cigna
CI
$76.6B
$1.76M 0.04%
13,167
+376
+3% +$49.2K
PFG icon
377
Principal Financial Group
PFG
$23.6B
$1.75M 0.04%
30,316
-86,431
-74% -$4.84M
BIO icon
378
Bio-Rad Laboratories Class A
BIO
$8.42B
$1.73M 0.04%
+9,500
New +$1.62M
CNC icon
379
Centene
CNC
$31.3B
$1.71M 0.04%
60,662
+7,854
+15% +$232K
ROST icon
380
Ross Stores
ROST
$76.6B
$1.71M 0.04%
26,082
-3,825
-13% -$250K
BF.B icon
381
Brown-Forman Class B
BF.B
$12B
$1.71M 0.04%
59,338
-1,890
-3% -$55.2K
CTMX icon
382
CytomX Therapeutics
CTMX
$705M
$1.7M 0.04%
155,000
– –
WR
383
DELISTED
Westar Energy Inc
WR
$1.67M 0.04%
+29,656
New +$1.69M
ICE icon
384
Intercontinental Exchange
ICE
$82.4B
$1.67M 0.04%
29,533
+2,893
+11% +$160K
PMC
385
DELISTED
PharMerica Corporation
PMC
$1.66M 0.04%
66,000
– –
GPC icon
386
Genuine Parts
GPC
$17.1B
$1.66M 0.04%
17,319
+40
+0.2% +$3.81K
EXPD icon
387
Expeditors International
EXPD
$22.9B
$1.65M 0.04%
31,114
+9,775
+46% +$511K
PLD icon
388
Prologis
PLD
$138B
$1.65M 0.04%
31,201
+4,566
+17% +$232K
SAGE
389
DELISTED
Sage Therapeutics
SAGE
$1.63M 0.04%
32,000
-7,000
-18% -$330K
K
390
DELISTED
Kellanova
K
$1.63M 0.04%
23,571
-41
-0.2% -$2.85K
ROK icon
391
Rockwell Automation
ROK
$51.4B
$1.63M 0.04%
12,122
-81
-0.7% -$10.3K
XEL icon
392
Xcel Energy
XEL
$51B
$1.62M 0.04%
39,844
+2,618
+7% +$105K
FPRX
393
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.6M 0.04%
32,000
+8,000
+33% +$420K
ALR
394
DELISTED
Alere Inc
ALR
$1.6M 0.04%
41,000
+3,000
+8% +$121K
OMED
395
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.6M 0.04%
207,000
+40,000
+24% +$368K
CTSH icon
396
Cognizant
CTSH
$21.5B
$1.59M 0.04%
28,438
-9,423
-25% -$504K
WU icon
397
Western Union
WU
$2.57B
$1.57M 0.04%
72,458
+16,595
+30% +$344K
RCI icon
398
Rogers Communications
RCI
$17.7B
$1.57M 0.04%
40,659
-7,045
-15% -$278K
GWPH
399
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.56M 0.04%
14,000
+3,000
+27% +$361K
NLY icon
400
Annaly Capital Management
NLY
$16.9B
$1.55M 0.04%
38,987
+4,110
+12% +$167K
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2016 Portfolio in Review

As of Q4 2016, Candriam SCA held 714 positions worth $4.36B, up 4.8% from $4.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA's Q4 2016 filing shows 57 new, 313 increased, 227 reduced and 46 closed positions. Its largest new stake was Coty: 555,452 shares worth $10.2M. The largest sale was Cisco, an estimated $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Financials and Technology.

  • Candriam SCA's largest Q4 2016 buy was Coty: 555,452 shares worth $10.2M.
  • Candriam SCA added most to Becton Dickinson in Q4 2016, an estimated $27.6M increase.
  • Candriam SCA's biggest Q4 2016 reduction was Cisco, cutting an estimated $26.2M.
  • Candriam SCA fully exited Harman International Industries in Q4 2016, selling an estimated $11.2M.
  • Candriam SCA's ten largest holdings make up 17% of its $4.36B portfolio in Q4 2016.
  • Candriam SCA opened 57 new positions and closed 46 in Q4 2016.
  • Candriam SCA's portfolio value rose 4.8% quarter-over-quarter to $4.36B.

Based on Candriam SCA's 13F filing for Q4 2016, filed 2 Feb 2017.